Related Experiment Video
Updated: May 31, 2025

Automated Segmentation of Cortical Grey Matter from T1-Weighted MRI Images
Published on: January 7, 2019
Advanced Automated Model for Robust Bone Marrow Segmentation in Whole-body MRI
Fabian Bauer1, Jessica Kächele2, Juliane Bernhard3
1Division of Radiology, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany (F.B., M.G., H.P.S., S.D.); Division of Musculoskeletal Imaging and Intervention, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114 (F.B.).
An advanced automated bone marrow segmentation model for whole-body MRI in monoclonal plasma cell disorders (MPCD) shows reliable performance. This AI model accurately segments bone marrow spaces, even with severe pathologies across multiple centers.
Area of Science:
- Radiology and Medical Imaging
- Artificial Intelligence in Medicine
- Oncology
Background:
- Monoclonal plasma cell disorders (MPCD) require accurate assessment of bone marrow involvement.
- Whole-body MRI (WB-MRI) is a key imaging modality for MPCD.
- Automated segmentation of bone marrow spaces (BMS) can improve efficiency and consistency.
Purpose of the Study:
- To develop an advanced automated BMS segmentation model using nnU-Net for WB-MRI in MPCD.
- To validate the model's performance on multicenter datasets with diverse pathologies.
- To compare the advanced model against a previously established basic segmentation model.
Main Methods:
- Utilized a cohort of 210 WB-MRIs from 207 MPCD patients across 8 centers.
- Trained an nnU-Net algorithm on 186 T1-weighted WB-MRIs.
- Tested the model on independent datasets, including cases with extensive tumor load and varying image quality.
Main Results:
- Achieved high mean Dice scores for BMS segmentation: 0.89±0.13 (test set I) and 0.88±0.11 (test set II).
- Demonstrated significantly improved performance compared to a prior basic model (p<0.05).
- Accurately segmented bone marrow affected by pathologies, artifacts, and low imaging quality.
Conclusions:
- The advanced automated model provides reliable segmentation of BMS on multicenter WB-MRI data.
- The model is robust even in the presence of severe myeloma-related pathologies and imaging heterogeneity.
- This technology holds promise for improved quantitative analysis in MPCD management.

